Feature Story
FDA Grants Madorra Breakthrough Device Designation Status for Treatment of Moderate to Severe Vulvovaginal Atrophy
Sept. 8, 2021 -- Clinical Trials of Madorra Therapy System Show Promising Results for Treatment of Vulvovaginal Atrophy
press release
More Client & Industry News
Alio Receives 1st Prize from the Jon DeHaan Foundation for Innovation in Wearable Device for Continuous, Non-Invasive Monitoring of Potassium Imbalance
May 18-20, 2021 -- Since 2019, the Jon DeHaan Foundation has awarded distinguished grants within the framework of PCR Innovators Day. They once more supported cardiovascular innovation with two generous grants in 2021 during EuroPCR. read more
Aidar Health Receives CE Mark Approval for MouthLab, a Medical Tricorder Optimized for Rapid Health Assessment
Feb. 16, 2021 -- MouthLab is the world’s first rapid health assessment device that measures more than 10 vital health parameters in just 60 seconds, enabling a more personalized, data-driven, daily health monitoring tool for users and a real-time surveillance system for physicians. press release | StartUp Health podcast with CEO Sathya Elumalai
Partner Alio Featured in the GIANT Healthy Innovators Live TV Event
Jan. 14, 2021 -- GIANT Health runs a weekly live TV programme featuring passionate personalities in the world of health tech innovation. iO life science partner Alio's Founder and CEO, David Kuraguntla, is invited as a guest panelist in season 3, episode 1.
watch episode
Dec. 15, 2020
GS Lab and iO life science Partner to Accelerate Patient Centric Medical Device Development
Nov. 10, 2020
Alio Introduces Series of Studies for Clinical-Grade Noninvasive Wearable
Oct. 28, 2020
How an Implantable Dialysis Device May Extend Life for People with Kidney Failure
Oct. 13, 2020
Alessa Therapeutics Announces First Patient Enrolled in Biolen-PC Study for Localized Drug Delivery for Prostate Cancer
Sep. 21, 2020
Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant
Aug. 6, 2020
Oncodisc, Inc. Awarded Competitive Grant from the National Science Foundation to Develop Cancer Technology
